(Q36714774)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241907%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

review article

1 reference

title

MHC class I antigens and immune surveillance in transformed cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241907%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241907%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Angel Garcia-Lora

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241907%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

6

Federico Garrido

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241907%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Natalia Aptsiauri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241907%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Miguel Angel Lopez-Nevot

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241907%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Francisco Ruiz-Cabello

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241907%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241907%20AND%20SRC:MED&resulttype=core&format=json

International Review of Cytology

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241907%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

256

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241907%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

139-189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241907%20AND%20SRC:MED&resulttype=core&format=json

Regulation of tumor progression by anti-neoplastic T cell responses

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

High frequency of autologous anti-melanoma CTL directed against an antigen generated by a point mutation in a new helicase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Sequence organisation of the class II region of the human MHC.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Role of MHC gene products in immune regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Structure of the human class I histocompatibility antigen, HLA-A2

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Human tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Multiple mechanisms underlie HLA dysregulation in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Functions of nonclassical MHC and non-MHC-encoded class I molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Mechanisms of loss of HLA class I expression on colorectal tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

The TATA box binding protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Cancer; a biological approach. I. The processes of control

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β2‐microglobulin inactivation in MSI‐positive tumors and LMP7/TAP2 downregulation in MSI‐negative tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Involvement of the chaperone tapasin in HLA-B44 allelic losses in colorectal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Biological implications of HLA-DR expression in tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

High frequency of altered HLA class I phenotypes in invasive breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

High frequency of altered HLA class I phenotypes in laryngeal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

HLA class I expression in bladder carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Analysis of HLA expression in human tumor tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

High frequency of HLA-B44 allelic losses in human solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

HLA class I antigen loss, tumor immune escape and immune selection

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Mechanisms of tumor evasion.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

HLA class I defects in malignant lesions: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

The host-tumor immune conflict: from immunosuppression to resistance and destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Proteolysis: from the lysosome to ubiquitin and the proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Mechanisms of MHC class I-restricted antigen processing and cross-presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

The detailed distribution of HLA-A, B, C antigens in normal human organs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Chromosome loss with concomitant duplication and recombination both contribute most to loss of heterozygosity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

TGF-beta signaling in tumor suppression and cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

The innate immune response to tumors and its role in the induction of T-cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Loss of heterozygosity, a frequent but a non-exclusive mechanism responsible for HLA dysregulation in non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Development of cancer vaccines to activate cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Microsatellite analysis of microdissected tumor cells and 6p high density microsatellite analysis in head and neck squamous cell carcinomas with down-regulated human leukocyte antigen class I expression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

MHC class I expression in mice lacking the proteasome subunit LMP-7

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

HLA class I and II expression in rhabdomyosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

MHC class I and II antigens on gastric carcinomas and autologous mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

The biological consequences of altered MHC expression on tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Tumour immunology: MHC antigens and malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Accessory molecules in the assembly of major histocompatibility complex class I/peptide complexes: how essential are they for CD8(+) T-cell immune responses?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

MHC class I antigens, immune surveillance, and tumor immune escape.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

MHC antigens and tumor escape from immune surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Further evidence for depression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Natural history of HLA expression during tumour development.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Structure of the HLA class I region and expression of its resident genes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

MHC class I alleles and their exploration of the antigen-processing machinery

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

The enigma of the natural killer cell

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Expression of class I transplantation antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Distinct transcriptional pathways regulate basal and activated major histocompatibility complex class I expression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-A*0301 allele in a prostate carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Loss of HLA class-I alleles, heavy chains and β2-microglobulin in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Antigen processing by the proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Physical and functional association of the major histocompatibility complex class I heavy chain alpha3 domain with the transporter associated with antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

1 reference

7 January 2021

The functionality of HLA-G is emerging

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Alterations in Fas expression are characteristic of, but not solely responsible for, enhanced metastatic competence.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

In search of the 'missing self': MHC molecules and NK cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Immunology Signal sequences stop killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Tumor cell recognition by natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

HLA class I recognition by killer cell Ig-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Total loss of MHC class I is an independent indicator of good prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Epigenetic targets for immune intervention in human malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Invasion and metastasis control: implications for increased therapeutic index of antitumor drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Analysis of HLA-E expression in human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Variable receptors controlling activation and inhibition of NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Analysis of HLA class I expression in different metastases from two melanoma patients undergoing peptide immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Killer immunoglobulin-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with beta 2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Prognostic significance of cytokine modulation in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Immunological ignorance of solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Immune surveillance against a solid tumor fails because of immunological ignorance

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Mechanisms of MHC class I--restricted antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Does the immune system see tumors as foreign or self?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Expression of histocompatibility (HLA) antigens on tumor cells and normal cells from patients with melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

A new beta 2 microglobulin mutation found in a melanoma tumor cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

A weakly tumorigenic phenotype with high MHC class-I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Criteria to define HLA haplotype loss in human solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

MHC ligands and peptide motifs: first listing

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumour-cell variants expressing a single HLA-class-I allele

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

A listing of human tumor antigens recognized by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Degradation of cell proteins and the generation of MHC class I-presented peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Cross-presentation: underlying mechanisms and role in immune surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Loss of heterozygosity in the HLA class I region in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Complexity, contradictions, and conundrums: studying post-proteasomal proteolysis in HLA class I antigen presentation.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Immunodominance and tumor escape

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

1 reference

7 January 2021

Antigen-processing machinery breakdown and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

HLA class I antigen abnormalities and immune escape by malignant cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

A mutation determining the loss of HLA-A2 antigen expression in a cervical carcinoma reveals novel splicing of human MHC class I classical transcripts in both tumoral and normal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Selection of metastatic tumour phenotypes by host immune systems

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

The role of the proteasome activator PA28 in MHC class I antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Genes of the Major Histocompatibility Complex in Mouse and Man

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta2m fusion molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Cell biology of antigen processing in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Reconstitution of expression of H-2K region-encoded murine MHC class I glycoproteins in MHC class I-deficient B16BL6 melanoma cells affects the expression and function of antigen-processing machinery

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Human diversity in killer cell inhibitory receptor genes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

T cell defined tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

The great escape: Is immune evasion required for tumor progression?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Immunoreceptor tyrosine-based inhibition motifs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

The 26S proteasome: a molecular machine designed for controlled proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Tumor-induced death of immune cells: its mechanisms and consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Making sense of mass destruction: quantitating MHC class I antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

The discovery of MHC restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Immunosuppressive networks in the tumour environment and their therapeutic relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Heterogeneity of MHC-class-I antigens in clones of methylcholanthrene-induced tumors. Implications for local growth and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

HLA class I chromosomal region, genes, and products: facts and questions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

Aberrant DNA methylation in cancer: potential clinical interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7696%2807%2956005-5

7 January 2021

10.1016/S0074-7696(07)56005-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241907%20AND%20SRC:MED&resulttype=core&format=json

release_bul7tmwbobfe3hri7pq3jbkjy4

24 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bul7tmwbobfe3hri7pq3jbkjy4

24 November 2022

mapped directly with Wikidata item

1 reference